Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016–2017

In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathi, Priya, Shringarpure, Kalpita, Unnikrishnan, Bhaskaran, Chadha, Vineet Kumar, Acharya, Vishak, Nair, Abirami, Sagili, Karuna D., Shastri, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181943/
https://www.ncbi.nlm.nih.gov/pubmed/32310069
http://dx.doi.org/10.3201/eid2605.181992
Descripción
Sumario:In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.

Ejemplares similares